| Date | Presentations Provided to IRB Members |
| Mar 2024 | Medical Devices (pdf) |
| Feb 2024 | VA and IRB Review (pdf) |
| Jan 2024 | Criteria for Approval (pdf) |
| Dec 2023 | Expedited Review (pdf) |
| Nov 2023 | Non-Significant Risk (NSR) Determinations (pdf) |
| Oct 2023 | IND Exemptions (pdf) |
| Sept 2023 | Component Analysis (pdf) |
| Aug 2023 | Children's Findings (pdf) |
| Jun 2023 | Single IRB Review (pdf) |
| Mar 2023 | Recruitment (pdf) |
| Dec 2022 | Software Functions and Mobile Medical Apps (pdf) |
| Nov 2022 | Medical Devices (pdf) |
| Oct 2022 | VA and IRB Review (pdf) |
| Sept 2022 | Criteria for IRB Approval (pdf) |
| Aug 2022 | AAHRRP Re-Accreditation (pdf) |
| July 2022 | Revised NC definitions (pdf) |
| Jun 2022 | Revised UP definition (pdf) |
| May 2022 | Non-Significant Risk Devices |
| Apr 2022 | Controverted Issues April 2022 (pdf) |
| Mar 2022 | COI: Action Reports and Management Plans |
| Jan 2022 | IRB Member Conflicting Interests |
| Dec 2021 | Common Rule FDA (pdf) |
| Oct 2021 | Children’s Findings and Signature Requirements |
| Sept 2021 | Recruitment |
| Aug 2021` | Office of Human Subjects Research Presentation (pdf)
Short Form Consent Process (pdf) |
| July 2021 | HIPAA |
| Jun 2021 | Unanticipated Problems (pdf) |
| May 2021 | Expedited Review |
| Apr 2021 | Scientific and Scholarly Validity |
| Mar 2021 | COI: Action Reports and Management Plans |
| Feb 2021 | Component Analysis |
| Jan 2021 | Non-Significant Risk Devices |